Earnings

Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est

Jul 24, 2026 · 09:04 AM ET· updated 2h ago

Surgery Partners (NASDAQ:SGRY) affirms FY2026 sales outlook from $3.350 billion-$3.450 billion to $3.350 billion-$3.450 billion vs $3.408 billion estimate.

Why It Matters

Surgery Partners is sticking with its prediction that it will make between $3.35 and $3.45 billion next year. This is slightly lower than what many experts expected, so the company sounds cautious about growth.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

SGRY16.16

+0.94 (+6.18%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.